Background: The importance of detecting amyloid β (Aβ) in the early stages of Alzheimer's disease has markedly increased following the approval of Lecanemab, a disease-modifying drug. MRI is a non-invasive and less expensive rather than amyloid PET as gold standard for Aβ biomarker, but its clinical ability to detect Aβ has not been demonstrated. MRI phase information reflects paramagnetic substance including iron associated with Aβ aggregation. We have developed a novel approach utilizing multi-gradient echo (GRE) to perform texture analysis of the phase information, enabling visualization of Aβ. The primary aim of this study is to evaluate the diagnostic capabilities of this "Amyloid MRI" technique.

Method: The consecutive 48 participants (mean age: 72±10, mean MMSE: 25±4) who visited our memory clinic, and underwent both MRI and amyloid PET were enrolled. Amyloid PET images were visually interpreted as Aβ positive (n=30) or negative (n=18), and standardized uptake value ratio (SUVr) maps were generated. Multi-GRE images were acquired with a 3-Tesla MRI. We generated a phase slope map, i.e. a first-order linear estimate of the phase change in time, and segmented four anatomical regions-of-interest (ROI) for cortex-based analysis. Statistical analysis of texture features (mean, SD and entropy) derived from the phase slope map over each ROI was performed. We investigated the correlation between the mean value of regional SUVr and that of texture parameters of the phase slope map, and determined the optimal cut-off of a linear classifier by ROC analysis based on the diagnosis of amyloid PET.

Result: The correlation coefficients between the mean value of SUVr and the texture features of the phase slope map in parietal, PCCpre, frontal and temporal were 0.57 (p<0.0001), 0.56 (p<0.0001), 0.48 (p<0.0006) and 0.22 (p<0.22), respectively. The optimal cut-off values for diagnosing Aβ positive or negative showed a sensitivity of 83% (73-93%), specificity of 89% (74-103%) and accuracy of 85%(75-96%).

Conclusion: The texture features of the phase slope map could reflect the spatial aggregation pattern of Aβ. Our method highlighted the potential to visualize Aβ using MRI.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.086310DOI Listing

Publication Analysis

Top Keywords

phase slope
16
slope map
16
amyloid pet
12
texture features
8
suvr texture
8
phase
7
6
amyloid
5
biomarkers background
4
background detecting
4

Similar Publications

Background: This study aimed to assess how knee savers (KSs) and knee pads (KPs) alleviate risks of knee musculoskeletal disorders (MSDs) among roofers during various phases of shingle installation. These phases encompass (1) reaching for shingles, (2) placing shingles, (3) grabbing a nail gun, (4) moving to the first nailing position, (5) nailing shingles, (6) replacing the nail gun, and (7) returning to an upright position.

Methods: In a laboratory setting, nine male participants simulated the shingle installation task on a slope-adjustable roof platform (0°, 15°, and 30° slopes) under four intervention conditions: no intervention (NO); with KPs only (KP); with KSs only (KS); and with both KPs and KSs (BO).

View Article and Find Full Text PDF

Background: The importance of detecting amyloid β (Aβ) in the early stages of Alzheimer's disease has markedly increased following the approval of Lecanemab, a disease-modifying drug. MRI is a non-invasive and less expensive rather than amyloid PET as gold standard for Aβ biomarker, but its clinical ability to detect Aβ has not been demonstrated. MRI phase information reflects paramagnetic substance including iron associated with Aβ aggregation.

View Article and Find Full Text PDF

Background: Cognitive decline is often influenced by Alzheimer's disease (AD) pathology (e.g., beta-amyloid burden) and other pathology (e.

View Article and Find Full Text PDF

Technology and Dementia Preconference.

Alzheimers Dement

December 2024

School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.

Background: The success of therapeutic options for treatment of Alzheimer's disease (AD) and the growing emphasis for such treatment to commence in the pre-clinical phase makes it necessary to have robust empirical models of clinical disease progression to understand findings from clinical trials, allow clinicians to evaluate effects of new drugs, and to select individuals for future trials. Such models have been developed from relatively small samples, with incomplete data/substantial loss to follow-up. The ADOPIC consortium provides the largest complete AD natural history sample to date.

View Article and Find Full Text PDF

Objective: To evaluate the clinical efficacy of ultrafast dynamic contrast-enhanced (DCE)-MRI using a compressed sensing (CS) technique for differentiating benign and malignant soft-tissue tumors (STTs) and to evaluate the factors related to the grading of malignant STTs.

Materials And Methods: A total of 165 patients (96 male; mean age, 61 years), comprising 111 with malignant STTs and 54 with benign STTs according to the 2020 WHO classification, underwent DCE-MRI with CS between June 2018 and June 2023. The clinical, qualitative, and quantitative parameters associated with conventional MRI were also obtained.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!